Ocrevus 300 mg Injection 10 ml

Ocrevus 300 mg Injection 10 ml is used in the treatment of relapsing forms of multiple sclerosis and primary progressive multiple sclerosis (PPMS) in adults. Multiple sclerosis (MS) is a chronic neurological disorder that affects the central nervous system. It occurs when the immune system mistakenly attacks the protective covering around nerve fibres, disrupting communication between the brain and the rest of the body. This damage can cause many physical, cognitive, and emotional symptoms, impacting daily life and overall well-being.

Ocrevus 300 mg Injection 10 ml contains Ocrelizumab. It works by targeting and destroying certain types of immune cells called B cells. In multiple sclerosis, these B cells attack the myelin sheath, the protective covering that envelops nerve fibres in the brain and spinal cord. By destroying these B cells, Ocrevus 300 mg Injection 10 ml helps to reduce inflammation and slow down the progression of multiple sclerosis.

The dose and duration of treatment with Ocrevus 300 mg Injection 10 ml may vary depending on your medical condition. The common side effects of Ocrevus 300 mg Injection 10 ml include swelling or pain in hands, legs, arms, or feet; upper respiratory tract infections; cough; itchy skin; rash; nausea; headache; and dizziness. Most of these side effects gradually resolve on their own over time. However, consult the doctor if these side effects persist or worsen.

Inform your doctor if you are pregnant, breastfeeding, or planning a pregnancy. The doctor may suggest using reliable contraception methods during the treatment and for an additional six months following the last dose to prevent pregnancy. If you become pregnant while receiving Ocrevus 300 mg Injection 10 ml, immediately inform your doctor. You should also tell your baby's doctor if you received Ocrevus 300 mg Injection 10 ml during pregnancy, as this may impact the timing of certain vaccinations your baby will receive. Inform your doctor about all the medicines you are taking and about your pre-existing health conditions.

Ocrevus 300 mg Injection 10 ml targets and destroys B cells that attack the myelin sheath in multiple sclerosis, thereby reducing inflammation and slowing disease progression. Follow your doctor's instructions to achieve the maximum benefits of the treatment.

Before receiving Ocrevus 300 mg Injection 10 ml, inform your doctor if you have an active infection, a history of hepatitis B, or have had cancer. They may postpone or avoid treatment if you currently have an infection or cancer. If you have a history of hepatitis B, your doctor will closely monitor you for reactivation of the virus.  It is also essential to tell your doctor about any immune system disorders you may have, as these could influence your treatment plan.  Watch out for any signs of an injection reaction and inform your doctor immediately if you experience any. Ocrevus 300 mg Injection 10 ml may increase infection risk, so inform your doctor if you have a fever, cough, or herpes. Worsening symptoms of multiple sclerosis could indicate a rare brain infection, so inform your doctor. Inform your partner or caregiver about your treatment with Ocrevus 300 mg Injection 10 ml, as they may be able to recognize subtle symptoms that you don't notice. Avoid live vaccines and discuss needed vaccinations with your doctor in advance. Ocrevus 300 mg Injection 10 ml is not recommended for children under 18 years of age, as its safety and efficacy were not established. Tell your doctor if you are pregnant, plan to become pregnant, or become pregnant while receiving Ocrevus 300 mg Injection 10 ml, or if you are breastfeeding, as this may affect your treatment and the health of your baby. Inform your doctor about all the medicines, supplements and vitamins you are currently taking to help identify potential interactions and minimize the side effects.